Search | Caixin

GO

Sort by: Newest
Newest Relevance Oldest
Type: All
All News CX Tech Videos Podcast Gallery In-Depth
Time: Any Time
Any time Past 24 Hours Past Week Past Month Past Year Custom Range
Range: All
All Headline Byline Full Text

Reset

Showing search results for "Fosun"

Fosun Posts $3.4 Billion Loss on Property, Asset Write-Downs

Chinese conglomerate Fosun International Ltd. reported a net loss of 23.4 billion yuan ($3.4
In Depth: Global Capital, Chinese AI Converge in Hong Kong

, however, may complicate valuations, said an investment manager at Fosun Asset Management. Most large
Chinese AI Startups Extend Post-Listing Rally in Hong Kong

, which remain scarce in China’s equity market. An investment executive at Fosun Asset Management Ltd
In Depth: The Battle to Make Cancer’s ‘Living Drug’ Affordable

of expectations. Fosun Kite Biotechnology Co. Ltd.’s Yescarta (Yikaida), the first CAR-T approved
Exclusive: Beijing Drafts Rules to Link Private Insurance With Pricey Innovative Medicines

implementation was highlighted by a recent reversal at Fosun United Health Insurance. On Dec. 16
China Opens New Insurance Path for High-Cost Drugs

talks for the commercial list. Fosun Kite’s axicabtagene ciloleucel and JW Therapeutics
In Depth: China’s Pharma Pioneers in Africa Dig In for the Long Haul

. ( 600079.SH ) and Shanghai Fosun Pharmaceutical Group Co. Ltd. ( 600196.SH ) have established
In Depth: Lawsuits Lay Bare Shortcomings of China’s Commercial Insurers

Mengda bought a children’s critical illness policy for her four-month-old son, Haohao, from Fosun United
In Depth: New Innovative Drug List Could Expand Access to Costly Breakthroughs

Ltd., IASO Bio and CARsgen Therapeutics Ltd. Others, including Shanghai Fosun Kairos Biotechnology
Hong Kong Regulators Issue Warning to Cool Stablecoin Frenzy

. 12, when Tencent News reported that Fosun International Chairman Guo Guangchang led a delegation

OR